275 related articles for article (PubMed ID: 18785179)
1. Insulin receptor expression by human prostate cancers.
Cox ME; Gleave ME; Zakikhani M; Bell RH; Piura E; Vickers E; Cunningham M; Larsson O; Fazli L; Pollak M
Prostate; 2009 Jan; 69(1):33-40. PubMed ID: 18785179
[TBL] [Abstract][Full Text] [Related]
2. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
Ryan CJ; Haqq CM; Simko J; Nonaka DF; Chan JM; Weinberg V; Small EJ; Goldfine ID
Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade.
Liao Y; Abel U; Grobholz R; Hermani A; Trojan L; Angel P; Mayer D
Hum Pathol; 2005 Nov; 36(11):1186-96. PubMed ID: 16260272
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
[TBL] [Abstract][Full Text] [Related]
5. Candidate genes involved in enhanced growth of human prostate cancer under high fat feeding identified by microarray analysis.
Narita S; Tsuchiya N; Saito M; Inoue T; Kumazawa T; Yuasa T; Nakamura A; Habuchi T
Prostate; 2008 Feb; 68(3):321-35. PubMed ID: 18175332
[TBL] [Abstract][Full Text] [Related]
6. High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers.
Halmos G; Arencibia JM; Schally AV; Davis R; Bostwick DG
J Urol; 2000 Feb; 163(2):623-9. PubMed ID: 10647698
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of insulin-like growth factor binding proteins in high versus low Gleason score prostate cancer.
Figueroa JA; De Raad S; Tadlock L; Speights VO; Rinehart JJ
J Urol; 1998 Apr; 159(4):1379-83. PubMed ID: 9507888
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells.
Chisalita SI; Nitert MD; Arnqvist HJ
Growth Horm IGF Res; 2006 Aug; 16(4):258-66. PubMed ID: 16914341
[TBL] [Abstract][Full Text] [Related]
9. IGF-I/insulin hybrid receptors in human endothelial cells.
Nitert MD; Chisalita SI; Olsson K; Bornfeldt KE; Arnqvist HJ
Mol Cell Endocrinol; 2005 Jan; 229(1-2):31-7. PubMed ID: 15607526
[TBL] [Abstract][Full Text] [Related]
10. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
[TBL] [Abstract][Full Text] [Related]
12. Effects of hyperglycemia on the differential expression of insulin and insulin-like growth factor-I receptors in human normal peritoneal and adhesion fibroblasts.
Rizk NN; Saed GM; Diamond MP
Fertil Steril; 2006 Oct; 86(4 Suppl):1217-22. PubMed ID: 16962112
[TBL] [Abstract][Full Text] [Related]
13. Influence of insulin resistance on adiponectin receptor expression in breast cancer.
Pfeiler G; Treeck O; Wenzel G; Goerse R; Hartmann A; Schmitz G; Ortmann O
Maturitas; 2009 Jul; 63(3):253-6. PubMed ID: 19524379
[TBL] [Abstract][Full Text] [Related]
14. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer.
Kawada M; Inoue H; Masuda T; Ikeda D
Cancer Res; 2006 Apr; 66(8):4419-25. PubMed ID: 16618768
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction.
Massoner P; Haag P; Seifarth C; Jurgeit A; Rogatsch H; Doppler W; Bartsch G; Klocker H
Prostate; 2008 Aug; 68(11):1165-78. PubMed ID: 18459102
[TBL] [Abstract][Full Text] [Related]
17. Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium.
Sutherland BW; Knoblaugh SE; Kaplan-Lefko PJ; Wang F; Holzenberger M; Greenberg NM
Cancer Res; 2008 May; 68(9):3495-504. PubMed ID: 18451178
[TBL] [Abstract][Full Text] [Related]
18. Implications of insulin-like growth factor-I for prostate cancer therapies.
Kojima S; Inahara M; Suzuki H; Ichikawa T; Furuya Y
Int J Urol; 2009 Feb; 16(2):161-7. PubMed ID: 19183230
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an antibody that can detect an activated IGF-I receptor in human cancers.
Rubini M; D'Ambrosio C; Carturan S; Yumet G; Catalano E; Shan S; Huang Z; Criscuolo M; Pifferi M; Baserga R
Exp Cell Res; 1999 Aug; 251(1):22-32. PubMed ID: 10438568
[TBL] [Abstract][Full Text] [Related]
20. Regulation of growth hormone receptors in human prostate cancer cell lines.
Bidosee M; Karry R; Weiss-Messer E; Barkey RJ
Mol Cell Endocrinol; 2009 Oct; 309(1-2):82-92. PubMed ID: 19540305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
